Page last updated: 2024-09-04

olmesartan and Collagenous Sprue

olmesartan has been researched along with Collagenous Sprue in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	5 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cartee, AK; Oxentenko, AS; Reyes Genere, JP	1
Lewin, M; Nielsen, JA; Steephen, A	1
Cano Ruiz, A; Crespo Pérez, L; Téllez Villajos, L	1
Arcand, R; Bensoussan, M; Désilets, E; Desruisseaux, C; Manière, T; Poirier, G; Tran, HK; Wisniewski, A	1
Arnason, T; Igoe, J; Kulai, T; MacIntosh, D	1

Reviews

3 review(s) available for olmesartan and Collagenous Sprue

Article	Year
[Non celiac villous atrophy: more confusion or a new syndrome?]. Medicina clinica, 2015, Feb-02, Volume: 144, Issue:3 Topics: Atrophy; Autoantibodies; Celiac Disease; Chronic Disease; Collagenous Sprue; Common Variable Immunodeficiency; Diagnosis, Differential; Diarrhea; Duodenum; Enteritis; Enterocytes; Eosinophilia; Gastritis; Humans; Imidazoles; Intestinal Mucosa; Malabsorption Syndromes; Microvilli; Polyendocrinopathies, Autoimmune; Tetrazoles	2015
Adding Water to the Mill: Olmesartan-Induced Collagenous Sprue-A Case Report and Brief Literature Review. Canadian journal of gastroenterology & hepatology, 2016, Volume: 2016 Topics: Aged; Antihypertensive Agents; Collagenous Sprue; Diarrhea; Humans; Hypertension; Imidazoles; Male; Tetrazoles; Withholding Treatment	2016
Duodenal Villous Atrophy in a TTG-Negative Patient Taking Olmesartan: A Case Report and Review of the Literature. Canadian journal of gastroenterology & hepatology, 2016, Volume: 2016 Topics: Aged; Antihypertensive Agents; Atrophy; Biopsy; Collagenous Sprue; Diarrhea; Duodenum; Humans; Hypertension; Imidazoles; Male; Tetrazoles; Vomiting; Weight Loss	2016

Other Studies

2 other study(ies) available for olmesartan and Collagenous Sprue

Article	Year
New Onset Villous Atrophy in a Patient With Celiac Disease. Gastroenterology, 2018, Volume: 155, Issue:4 Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Atrophy; Biopsy; Celiac Disease; Collagenous Sprue; Diet, Gluten-Free; Female; Humans; Hypertension; Imidazoles; Intestine, Small; Medication Therapy Management; Microvilli; Risk Factors; Tetrazoles	2018
Angiotensin-II inhibitor (olmesartan)-induced collagenous sprue with resolution following discontinuation of drug. World journal of gastroenterology, 2013, Oct-28, Volume: 19, Issue:40 Topics: Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Atrophy; Biopsy; Collagenous Sprue; Duodenoscopy; Duodenum; Female; Humans; Imidazoles; Middle Aged; Regeneration; Risk Factors; Tetrazoles; Time Factors; Treatment Outcome	2013

Article

Year

New Onset Villous Atrophy in a Patient With Celiac Disease.

Gastroenterology, 2018, Volume: 155, Issue:4

Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Atrophy; Biopsy; Celiac Disease; Collagenous Sprue; Diet, Gluten-Free; Female; Humans; Hypertension; Imidazoles; Intestine, Small; Medication Therapy Management; Microvilli; Risk Factors; Tetrazoles

2018

Angiotensin-II inhibitor (olmesartan)-induced collagenous sprue with resolution following discontinuation of drug.

World journal of gastroenterology, 2013, Oct-28, Volume: 19, Issue:40

Topics: Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Atrophy; Biopsy; Collagenous Sprue; Duodenoscopy; Duodenum; Female; Humans; Imidazoles; Middle Aged; Regeneration; Risk Factors; Tetrazoles; Time Factors; Treatment Outcome

2013